Literature DB >> 30887439

A Patient with Sjogren's Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis.

Jason Hom1,2, Shruti Marwaha3,4, Anna Postolova5, Jessie Kittle6, Rosaline Vasquez7, Jean Davidson3, Jennefer Kohler3, Annika Dries3, Liliana Fernandez-Betancourt3, Marta Majcherska3, Joanna Dearlove8, Shyam Raghavan9, Hannes Vogel9, Jonathan A Bernstein3,10, Paul Fisher3,11, Euan Ashley3,4, Jacinda Sampson3,8, Matthew Wheeler3,4.   

Abstract

We discuss a challenging case of a 58-year-old Vietnamese-American woman who presented to her new primary care provider with an 8-year history of slowly progressive dysphagia, hoarseness, muscle weakness with associated frequent falls, and weight loss. She eventually reported dry eyes and dry mouth, and she was diagnosed with Sjogren's syndrome. Subsequently, she was additionally diagnosed with inclusion body myositis and gastric light-chain (AL) amyloidosis. Although inclusion body myositis has been previously associated with Sjogren's syndrome, inclusion body myositis is rare in non-Caucasians, and the trio of Sjogren's syndrome, inclusion body myositis, and AL amyloidosis has not been previously reported. Sjogren's syndrome is a systemic autoimmune condition characterized by ocular and oral dryness. It is one of the most common rheumatologic disorders in the USA and worldwide. Early diagnosis of Sjogren's is particularly important given the frequency and variety of associated autoimmune diseases and extraglandular manifestations. Furthermore, although inclusion body myositis has a low prevalence, it is the most common inflammatory myopathy in older adults and is unfortunately associated with long delays in diagnosis, so knowledge of this disorder is also crucial for practicing internists.

Entities:  

Keywords:  Sjogren’s syndrome; amyloidosis; immunophenotyping; inclusion body myositis

Year:  2019        PMID: 30887439      PMCID: PMC6544676          DOI: 10.1007/s11606-019-04931-w

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  24 in total

Review 1.  Primary respiratory failure in inclusion body myositis.

Authors:  N C Voermans; M Vaneker; G J D Hengstman; H J ter Laak; C Zimmerman; H J Schelhaas; M J Zwarts
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

2.  Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.

Authors:  Kenneth C Parker; Sek Won Kong; Ronan J Walsh; Mohammad Salajegheh; Behzad Moghadaszadeh; Anthony A Amato; Remedios Nazareno; Yin Yin Lin; Bryan Krastins; David A Sarracino; Alan H Beggs; Jack L Pinkus; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-06       Impact factor: 3.217

Review 3.  Differential diagnosis generators: an evaluation of currently available computer programs.

Authors:  William F Bond; Linda M Schwartz; Kevin R Weaver; Donald Levick; Michael Giuliano; Mark L Graber
Journal:  J Gen Intern Med       Date:  2012-02       Impact factor: 5.128

4.  Prevalence of sporadic inclusion body myositis in Western Australia.

Authors:  B A Phillips; P J Zilko; F L Mastaglia
Journal:  Muscle Nerve       Date:  2000-06       Impact factor: 3.217

5.  The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.

Authors:  A Rojana-udomsart; M Needham; Y B Luo; V Fabian; S Walters; P J Zilko; F L Mastaglia
Journal:  Clin Neurol Neurosurg       Date:  2011-04-20       Impact factor: 1.876

6.  Primary Sjögren's syndrome associated with inclusion body myositis.

Authors:  P Kanellopoulos; C Baltoyiannis; A G Tzioufas
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

7.  Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.

Authors:  U A Badrising; G M Th Schreuder; M J Giphart; K Geleijns; J J G M Verschuuren; A R Wintzen; M L C Maat-Schieman; P van Doorn; B G M van Engelen; C G Faber; J E Hoogendijk; A E de Jager; P J Koehler; M de Visser; S G van Duinen
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

Review 8.  Inclusion body myositis in connective tissue disorders: case report and review of the literature.

Authors:  C T Derk; F B Vivino; L Kenyon; S Mandel
Journal:  Clin Rheumatol       Date:  2003-10       Impact factor: 2.980

9.  Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association.

Authors:  Antoinette Perlat; Olivier Decaux; Renaud Gervais; Nathalie Rioux; Bernard Grosbois
Journal:  Amyloid       Date:  2009       Impact factor: 7.141

10.  Performance of a web-based clinical diagnosis support system for internists.

Authors:  Mark L Graber; Ashlei Mathew
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

View more
  1 in total

1.  Case Report: Systemic Amyloidosis Involving the Heart and Skeletal Muscle.

Authors:  Pinchao Lv; Yuxi Li; Lin Wu; Qiuping Shi; Lingchao Meng; Xiaojuan Yu; Lin Nong; Jianping Li
Journal:  Front Cardiovasc Med       Date:  2022-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.